Brief: Sedana Medical Q2 EBIT Loss Widens To SEK 30 Million

Sedana Medical AB (publ)

21/07/2022 06:15

July 21 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL AB INTERIM REPORT JANUARY-JUNE 2022
    * Q2 NET SALES FOR QUARTER TOTALLED MSEK 27 (40), EQUIVALENT
TO A
DECREASE OF 32% COMPARED TO 2021
    * Q2 OPERATING INCOME (EBIT) TOTALLED MSEK -30 (-16),
EQUIVALENT
TO AN EBIT MARGIN OF -111% (-41%)
    * Q2 GROSS PROFIT WAS MSEK 19 (26), EQUIVALENT TO A MARGIN
OF 70%
(66%)
    * WE CONTINUED TO SEE A SIGNIFICANT CONTRACTION OF OUR
ADDRESSABLE
MARKET ACROSS OUR MAIN GEOGRAPHIES

Source text for Eikon:  ID:nWkr9nNYQy 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))